Featured ArticlesLatest NewsThe Latest

Streamlining Psoriatic Arthritis Screening and Management Using the IDEOM Clinical Framework: A Quality Improvement Initiative

By August 13, 2025No Comments
Journal of Drugs in Dermatology JDD Article About The Prevalence of Dupilumab-Associated Adverse Events Among Black and African American Adult Patients With Atopic Dermatitis: A Retrospective Chart Review

Transforming Routine Visits into Early‐Warning Systems for Psoriatic Arthritis

What if every psoriasis appointment could double as a stealth screening for psoriatic arthritis? In one of our latest JDD articles titled “Streamlining Psoriatic Arthritis Screening and Management Using the IDEOM Clinical Framework,” dermatology clinics across a large health system embedded two simple questionnaires—the PEST and PsAID-12—directly into their electronic health record. This seamless integration lets providers flag worrisome symptoms in real time, prompting earlier treatment adjustments or rheumatology referrals before irreversible joint damage could take hold.

This isn’t theory, it’s a practical, clinic-friendly approach that has already reshaped care for hundreds of patients without adding extra paperwork. By routinely capturing patient-reported outcomes at the point of care, dermatologists gained a clearer view of each patient’s joint health trajectory and saw meaningful improvements in long-term symptom control.

Curious how your practice could leverage this framework to catch psoriatic arthritis sooner, personalize treatment plans, and strengthen collaboration with rheumatology? Read the full article to explore how IDEOM’s clinical workflow can fit into your clinic—and help you protect your patients from silent, preventable joint damage.

Blog write-up assisted by AI